Literature DB >> 14740126

[Locally recurrent rectal carcinoma].

Th Lehnert1, M Golling, J Buchholz.   

Abstract

There is no doubt that surgical treatment with curative intent is warranted in patients with recurrent colorectal cancer. This is also true for locally recurrent rectal cancer. Operative procedures are demanding but may be curative if complete excision can be achieved. Preoperative radiochemotherapy has helped to improve resectability, but operative morbidity is still high. Procedure-related mortality on the other hand is low, at around 3%, and 25% 5-year survival can be expected after complete excision.

Entities:  

Mesh:

Year:  2004        PMID: 14740126     DOI: 10.1007/s00104-003-0795-3

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  35 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group.

Authors:  K M Tveit; I Guldvog; S Hagen; E Trondsen; T Harbitz; K Nygaard; J B Nilsen; E Wist; E Hannisdal
Journal:  Br J Surg       Date:  1997-08       Impact factor: 6.939

3.  Improved survival with preoperative radiotherapy in resectable rectal cancer.

Authors:  B Cedermark; M Dahlberg; B Glimelius; L Påhlman; L E Rutqvist; N Wilking
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245

4.  Abdominoperineal excision of the rectum--an endangered operation. Norman Nigro Lectureship.

Authors:  R J Heald; R K Smedh; A Kald; R Sexton; B J Moran
Journal:  Dis Colon Rectum       Date:  1997-07       Impact factor: 4.585

5.  Surgeon-related factors and outcome in rectal cancer.

Authors:  G A Porter; C L Soskolne; W W Yakimets; S C Newman
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

6.  Comparison of intraoperative radiation therapy-containing multimodality treatment with historical treatment modalities for locally recurrent rectal cancer.

Authors:  G H Mannaerts; H J Rutten; H Martijn; P E Hanssens; T Wiggers
Journal:  Dis Colon Rectum       Date:  2001-12       Impact factor: 4.585

7.  Radical surgery and postoperative radiotherapy as combined treatment in rectal cancer. Final results of a phase III study of the European Organization for Research and Treatment of Cancer.

Authors:  J P Arnaud; B Nordlinger; J F Bosset; G H Boes; T Sahmoud; P M Schlag; F Pene
Journal:  Br J Surg       Date:  1997-03       Impact factor: 6.939

8.  Evaluation of preoperative radiation therapy in operable colorectal cancer.

Authors:  W T Sause; T F Pajak; R D Noyes; R Dobelbower; J Fischbach; S Doggett; M Mohiuddin
Journal:  Ann Surg       Date:  1994-11       Impact factor: 12.969

9.  Long-term results of a randomised trial of short-course low-dose adjuvant pre-operative radiotherapy for rectal cancer: reduction in local treatment failure.

Authors:  P A Goldberg; R J Nicholls; N H Porter; S Love; J E Grimsey
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

10.  The mesorectum in rectal cancer surgery--the clue to pelvic recurrence?

Authors:  R J Heald; E M Husband; R D Ryall
Journal:  Br J Surg       Date:  1982-10       Impact factor: 6.939

View more
  3 in total

Review 1.  [Therapy of locally recurrent rectal carcinoma].

Authors:  H G Hempen; H R Raab
Journal:  Chirurg       Date:  2009-04       Impact factor: 0.955

2.  Locally recurrent colorectal cancer: results of surgical therapy.

Authors:  M Kruschewski; M Ciurea; S Lipka; S Daum; L Moser; B Meyer; J Gröne; J Budczies; H J Buhr
Journal:  Langenbecks Arch Surg       Date:  2012-06-28       Impact factor: 3.445

Review 3.  [Curative vs palliative strategies in locoregional recurrence of gastrointestinal malignancies].

Authors:  J R Siewert; F Lordick; K Ott; B L D M Brücher; R Rosenberg
Journal:  Chirurg       Date:  2006-03       Impact factor: 0.955

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.